NYSE:CSLT - Castlight Health Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $2.00
  • Forecasted Upside: 34.23 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.49
▲ +0.05 (3.47%)

This chart shows the closing price for CSLT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Castlight Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CSLT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CSLT

Analyst Price Target is $2.00
▲ +34.23% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Castlight Health in the last 3 months. The average price target is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 34.23% upside from the last price of $1.49.

This chart shows the closing price for CSLT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 contributing investment analysts is to hold stock in Castlight Health. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
3/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2021Canaccord GenuityBoost Price TargetHold$1.00 ➝ $2.00Low
7/29/2020Canaccord GenuityReiterated RatingHold$1.00High
5/19/2020Wells Fargo & CompanyLower Price TargetUnderweight$1.15 ➝ $0.75High
5/14/2020Canaccord GenuityReiterated RatingHoldMedium
2/27/2020Canaccord GenuityReiterated RatingHold$1.50High
2/26/2020Cantor FitzgeraldReiterated RatingNeutral$3.00 ➝ $2.00High
1/8/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$1.75 ➝ $1.20High
11/27/2019Canaccord GenuityLower Price Target$4.00 ➝ $1.50Low
11/20/2019Canaccord GenuityDowngradeBuy ➝ Hold$4.00 ➝ $1.50Low
7/30/2019Cantor FitzgeraldDowngradeOverweight ➝ NeutralHigh
12/20/2018William BlairReiterated RatingOutperformHigh
12/17/2018Cantor FitzgeraldReiterated RatingBuy$5.00Medium
10/31/2018Dougherty & CoLower Price TargetBuy ➝ Buy$6.00 ➝ $5.00High
10/18/2018William BlairReiterated RatingBuyMedium
8/17/2018Cantor FitzgeraldReiterated RatingBuy$5.00High
7/31/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$7.00 ➝ $6.00High
7/31/2018Chardan CapitalDowngradeBuy ➝ Neutral$6.00 ➝ $4.80High
7/23/2018Dougherty & CoBoost Price TargetBuy$6.00 ➝ $7.00Low
6/20/2018William BlairInitiated CoverageOutperformHigh
5/11/2018Chardan CapitalBoost Price TargetBuy ➝ Buy$5.75 ➝ $6.00Medium
5/10/2018Cantor FitzgeraldReiterated RatingBuy$5.00Medium
4/25/2018Cantor FitzgeraldReiterated RatingBuy$5.00High
2/22/2018Chardan CapitalReiterated RatingBuy ➝ Buy$6.30 ➝ $5.75Low
2/21/2018Cantor FitzgeraldReiterated RatingBuy$5.00Low
1/30/2018Cantor FitzgeraldUpgradeNeutral ➝ Overweight$5.00Medium
10/26/2017Canaccord GenuityReiterated RatingBuy$7.00N/A
10/26/2017Chardan CapitalLower Price TargetBuy$6.50 ➝ $6.30N/A
10/25/2017Cantor FitzgeraldReiterated RatingHold$5.00N/A
10/10/2017Canaccord GenuityUpgradeHold ➝ BuyN/A
8/17/2017Dougherty & CoReiterated RatingBuyMedium
8/3/2017CowenReiterated RatingMarket Perform$4.00 ➝ $4.50High
6/6/2017Chardan CapitalInitiated CoverageBuy$4.50Medium
5/12/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$4.00 ➝ $3.75High
5/10/2017Dougherty & CoInitiated CoverageBuy ➝ Buy$5.50High
3/8/2017CowenReiterated RatingMarket Perform$4.00Low
3/3/2017Canaccord GenuityReiterated RatingHold$5.00N/A
2/23/2017Cantor FitzgeraldReiterated RatingHold$4.50N/A
1/30/2017CowenInitiated CoverageMarket Perform$4.00N/A
1/27/2017Canaccord GenuityReiterated RatingHold$5.00N/A
1/5/2017Cantor FitzgeraldInitiated CoverageNeutral$4.50N/A
1/5/2017Raymond JamesReiterated RatingOutperform ➝ Market PerformN/A
(Data available from 12/7/2016 forward)

News Sentiment Rating

0.27 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/11/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/10/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/9/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/8/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/8/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/7/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021

Current Sentiment

  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Castlight Health logo
Castlight Health, Inc. engages in the provision of healthcare information technology solutions. It offers health benefits platforms which enables benefit leaders to communicate and measure their programs. The company was founded by Todd Y. Park, Bryan E. Roberts and Giovanni M. Colella in January 2008 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $1.49
Low: $1.45
High: $1.54

50 Day Range

MA: $1.70
Low: $1.40
High: $1.93

52 Week Range

Now: $1.49
Low: $1.18
High: $2.71

Volume

455,539 shs

Average Volume

1,191,698 shs

Market Capitalization

$241.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Castlight Health?

The following Wall Street analysts have issued reports on Castlight Health in the last twelve months: Canaccord Genuity, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CSLT.

What is the current price target for Castlight Health?

1 Wall Street analysts have set twelve-month price targets for Castlight Health in the last year. Their average twelve-month price target is $2.00, suggesting a possible upside of 34.2%. Canaccord Genuity has the highest price target set, predicting CSLT will reach $2.00 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of $2.00 for Castlight Health in the next year.
View the latest price targets for CSLT.

What is the current consensus analyst rating for Castlight Health?

Castlight Health currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CSLT, but not buy more shares or sell existing shares.
View the latest ratings for CSLT.

What other companies compete with Castlight Health?

How do I contact Castlight Health's investor relations team?

Castlight Health's physical mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker's listed phone number is (415) 829-1400 and its investor relations email address is [email protected] The official website for Castlight Health is www.castlighthealth.com.